A new scientific statement identifies the risks and benefits of novel interventional devices compared to anticoagulation alone in the treatment of patients with pulmonary embolism. Authors conclude there is little data -- particularly, as it pertains to the treatment of patients with 'intermediate-risk PE' -- that suggests these interventional approaches are more safe and effective than the use of anticoagulation alone.
A new type of drug that blocks one of cancer's key evolutionary escape routes from chemotherapy could be used to treat aggressive breast cancers, a new study has shown.
Many admissions to the intensive care unit may be preventable, potentially decreasing health care costs and improving care, according to new research.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου